news

High Street Capital Acquires Avomeen

2016 November

We are pleased to announce we have acquired a controlling interest in Avomeen Analytical Services, LLC (“Avomeen” or the “Company”). Avomeen is a full-service chemical testing laboratory with unique product testing and formulation development expertise. The Company specializes in deformulation analysis (reverse engineering), research and development support, stability testing, litigation support services, failure analysis and pharmaceutical analysis and testing. For more information regarding Avomeen’s services, please visit www.Avomeen.com.

Dr. Shri Thanedar, Avomeen’s founder and CEO, stated, “Avomeen chose to partner with High Street Capital as we were impressed with their complimentary skills in sales and marketing, financial management and operational expertise. With High Street, we won’t be just another portfolio company. Their plans to retain all current employees and my ability to retain substantial ownership were important considerations in closing this deal. I look forward to working with the High Street Capital team to build on our foundation of technological excellence and outstanding customer service.”

This acquisition represents High Street’s seventh platform investment for Fund IV.  Rob France, an HSC Principal, commented, “Dr. Thanedar was looking for a partner to continue Avomeen’s rapid growth through opening new labs near key customers, completing acquisitions and rounding out the Company’s infrastructure.  High Street Capital brings relationships, capital and expertise to help Dr. Thanedar and his team execute upon this growth plan.”

We are actively seeking add-on acquisitions for Avomeen.  Please contact Rob France at 312.423.2653 or via rob@highstreetcapital.com with any opportunities which might be a fit.

We are also seeking new platform investment opportunities for High Street Capital IV in the areas of outsourced business services, value-added distribution and manufacturing.  Please contact us for businesses with revenues between $10 million and $100 million where our capital, experience and ideas could drive future growth.